Theravance Biopharma (TBPH) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Theravance Biopharma (TBPH) over the last 12 years, with Q3 2025 value amounting to 0.19.
- Theravance Biopharma's Asset Utilization Ratio rose 848.09% to 0.19 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19, marking a year-over-year increase of 848.09%. This contributed to the annual value of 0.17 for FY2024, which is 5068.27% up from last year.
- As of Q3 2025, Theravance Biopharma's Asset Utilization Ratio stood at 0.19, which was up 848.09% from 0.2 recorded in Q2 2025.
- Theravance Biopharma's Asset Utilization Ratio's 5-year high stood at 0.2 during Q2 2025, with a 5-year trough of 0.06 in Q4 2022.
- In the last 5 years, Theravance Biopharma's Asset Utilization Ratio had a median value of 0.14 in 2023 and averaged 0.14.
- As far as peak fluctuations go, Theravance Biopharma's Asset Utilization Ratio tumbled by 7414.99% in 2021, and later soared by 14341.57% in 2023.
- Over the past 5 years, Theravance Biopharma's Asset Utilization Ratio (Quarter) stood at 0.14 in 2021, then plummeted by 58.3% to 0.06 in 2022, then surged by 143.42% to 0.14 in 2023, then rose by 25.58% to 0.18 in 2024, then increased by 5.31% to 0.19 in 2025.
- Its last three reported values are 0.19 in Q3 2025, 0.2 for Q2 2025, and 0.19 during Q1 2025.